Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease? (Q39072124)

8 September 2017

title

Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease? (English)

1 reference

8 September 2017

1 reference

Dominic Ngima Nthenge-Ngumbau

series ordinal

1

1 reference

8 September 2017

Kochupurackal P Mohanakumar

series ordinal

2

1 reference

8 September 2017

publication date

6 January 2017

1 reference

8 September 2017

published in

Molecular Neurobiology

1 reference

The prevalence of Parkinson's disease: a systematic review and meta-analysis

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Levodopa-induced dyskinesia and thalamotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Randomized trial of pallidotomy versus medical therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Surgical treatment for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Deep brain stimulation mechanisms: the control of network activity via neurochemistry modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Physiological and anatomical decomposition of subthalamic neurostimulation effects in essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Histological alterations induced by electrode implantation and electrical stimulation in the human brain: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Dopamine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

The distribution of phosphodiesterase 2A in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

An easy method to check the efficiency of biotin end-labelling of DNA-fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Advances in targeting cyclic nucleotide phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterases in the CNS: targets for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression of PDE8B in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Inactivation of Pde8b enhances memory, motor performance, and protects against age-induced motor coordination decay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Identification and Characterization of a Novel Family of Cyclic Nucleotide Phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Isolation and characterization of PDE10A, a novel human 3', 5'-cyclic nucleotide phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Immunohistochemical localization of PDE10A in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

3',5'-cyclic nucleotide phosphodiesterase 11A: localization in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Does phosphodiesterase 11A (PDE11A) hold promise as a future therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterase 11 (PDE11): is it a player in human testicular function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Signaling in striatal neurons: the phosphoproteins of reward, addiction, and dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

A new therapeutic approach in Parkinson's disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′,5′-cyclic nucleotide phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developing and mature rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Novel approaches to targeting PDE3 in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterase 3A (PDE3A) Deletion Suppresses Proliferation of Cultured Murine Vascular Smooth Muscle Cells (VSMCs) via Inhibition of Mitogen-activated Protein Kinase (MAPK) Signaling and Alterations in Critical Cell Cycle Regulatory Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Tyrosine hydroxylase phosphorylation: regulation and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: determination of blood-brain barrier penetration and binding to human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterases in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

A novel mutation of PDE8B Gene in a Japanese family with autosomal-dominant striatal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterase 10A inhibitor, MP-10 (PF-2545920), produces greater induction of c-Fos in dopamine D2 neurons than in D1 neurons in the neostriatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Cyclic Nucleotide Phosphodiesterase 1 Regulates Lysosome-Dependent Type I Collagen Protein Degradation in Vascular Smooth Muscle Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Role of Ca2 /calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Object memory enhancement by combining sub-efficacious doses of specific phosphodiesterase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

A novel PDE2A reporter cell line: characterization of the cellular activity of PDE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

In permanent atrial fibrillation, PDE3 reduces force responses to 5-HT, but PDE3 and PDE4 do not cause the blunting of atrial arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Myocardial Response to Milrinone in Single Right Ventricle Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8 T-lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Antispasmodic action of 1-diethylaminoethyl-3-(p-methoxybenzyl)-2-quinoxalone (P 201-1) and its inhibitory effect on cyclic 3',5'-nucleotide phosphodiesterase (PDE) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Influence of papaverine derivatives on phosphodiesterase activity, cyclic 3?,5?-AMP levels and relaxing effect on rabbit ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Disruption of CREB function in brain leads to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

CREB couples neurotrophin signals to survival messages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Effects of glial cell line-derived neurotrophic factor (GDNF) on dopaminergic neurons require concurrent activation of cAMP-dependent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

The relationship between neuronal survival and regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Gnaphaliin A and B relax smooth muscle of guinea-pig trachea and rat aorta via phosphodiesterase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-0355-8

Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation

21 January 2018

1 reference

12 December 2020

Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation

1 reference

12 December 2020

Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain.

1 reference

12 December 2020

3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition

1 reference

12 December 2020

1,5-Substituted nipecotic amides: selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability

1 reference

12 December 2020

TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS

1 reference

12 December 2020

Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning

1 reference

12 December 2020

In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides

1 reference

12 December 2020

Cyclic AMP promotes the survival of dopaminergic neurons in vitro and protects them from the toxic effects of MPP

1 reference

12 December 2020

Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain

1 reference

12 December 2020

Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model

1 reference

12 December 2020

Lesioning the subthalamic nucleus in the treatment of Parkinson's disease

1 reference

12 December 2020

Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants

1 reference

12 December 2020

Rolipram, a Phosphodiesterase-4-Selective Inhibitor, Promotes the Survival of Cultured Rat Dopaminergic Neurons

1 reference

12 December 2020

Therapeutic use of a selective cAMP phosphodiesterase inhibitor (Rolipram) in parkinson's disease

1 reference

12 December 2020

Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes

1 reference

12 December 2020

The regulation of sGC on the rat model of neuropathic pain is mediated by 5-HT1ARs and NO/cGMP pathway

1 reference

12 December 2020

Regulation of dopamine signaling in the striatum by phosphodiesterase inhibitors: novel therapeutics to treat neurological and psychiatric disorders.

1 reference

12 December 2020

Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation.

1 reference

12 December 2020

Inhibitors of Type IV Phosphodiesterases Reduce the Toxicity of MPTP in Substantia Nigra NeuronsIn Vivo

1 reference

12 December 2020

The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors.

1 reference

12 December 2020

Discovery of oxazole-based PDE4 inhibitors with picomolar potency

1 reference

12 December 2020

Phosphodiesterase Targets for Cognitive Dysfunction and Schizophrenia--a New York Academy of Sciences Meeting.

1 reference

12 December 2020

Discovery of a highly potent series of oxazole-based phosphodiesterase 4 inhibitors

1 reference

12 December 2020

10.1007/S12035-016-0355-8

Identifiers

DOI

1 reference

8 September 2017

1 reference